Tenet Healthcare Corporation (THC)
Why Tenet Healthcare (THC) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet Healthcare Corporation (THC) Q1 2025 Earnings Call Transcript
Tenet Healthcare Corporation (NYSE:THC ) Q1 2025 Earnings Conference Call April 29, 2025 10:00 AM ET Company Participants William McDowell - Vice President-Investor Relations Saum Sutaria - Chairman and Chief Executive Officer Sun Park - Executive Vice President and Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Craig Hettenbach - Morgan Stanley Investment Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Megan Holt - Jefferies Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Ben Hendrix - RBC Capital Markets Whit Mayo - Leerink Partners Ann Hynes - Mizuho Securities Benjamin Rossi - JPMorgan Chase A.J. Rice - UBS Andrew Mok - Barclays Josh Raskin - Nephron Research Operator Good morning and welcome to Tenet Healthcare's First Quarter 2025 Earnings Conference Call.
Tenet (THC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Stay Ahead of the Game With Tenet (THC) Q1 Earnings: Wall Street's Insights on Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Tenet (THC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
Tenet Healthcare (THC) Stock Drops Despite Market Gains: Important Facts to Note
In the most recent trading session, Tenet Healthcare (THC) closed at $122.10, indicating a -1.72% shift from the previous trading day.
All You Need to Know About Tenet (THC) Rating Upgrade to Buy
Tenet (THC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wall Street Analysts Think Tenet (THC) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet Healthcare (THC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Tenet Healthcare (THC) Beats Stock Market Upswing: What Investors Need to Know
Tenet Healthcare (THC) closed at $124.91 in the latest trading session, marking a +0.9% move from the prior day.
